Response of Normal Tissues to Boron Neutron Capture Therapy (BNCT) with <sup>10</sup>B-Borocaptate Sodium (BSH) and <sup>10</sup>B-Paraboronophenylalanine (BPA)
Boron neutron capture therapy (BNCT) is a cancer-selective radiotherapy that utilizes the cancer targeting <sup>10</sup>B-compound. Cancer cells that take up the compound are substantially damaged by the high liner energy transfer (LET) particles emitted mainly from the <sup>10<...
| Published in: | Cells |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-10-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/10/11/2883 |
